ACS Medicinal Chemistry Letters

Basic Information

Brief Name: ACS Med. Chem. Lett.
Impact Factor: 3.5
ISSN: 1948-5875
Research Field: MEDICAL
h-index: 52
Self-citation Rate: 5.7%
Articles per Year: 216

SCI Index Status: Science Citation Index Expanded
Journal Website: https://pubs.acs.org/journal/amclct
Journal Introduction:

ACS Medicinal Chemistry Letters is interested in receiving manuscripts that discuss various aspects of medicinal chemistry. The journal will publish studies that pertain to a broad range of subject matter, including compound design and optimization, biological evaluation, drug delivery, imaging agents, drug interactome studies, and pharmacology of both small and large bioactive molecules. Specific areas include but are not limited to: Identification, synthesis, and optimization of lead biologically active molecules and drugs (small molecules and biologics) Biological characterization of new molecular entities in the context of drug discovery towards delineating structure-activity relationship (SAR) trends Computational, cheminformatics, and structural studies for the identification or SAR analysis of bioactive molecules, ligands, and their targets, etc. Use of artificial intelligence and machine learning in drug discovery Novel and improved methodologies, including radiation biochemistry, with broad application to medicinal chemistry if the methods have been tested on relevant molecules. (e.g. DNA-encoded libraries, high-throughput experimentation, high-throughput parallel synthesis- compound library production, fragment-based drug discovery, covalent modulators.) New developments in discovery screening and bioassay technologies for biologically active molecules from both synthetic and natural (plant and other) sources. Chemistry patents relevant to the medicinal chemistry field Studies involving proximity-inducing agents including targeted protein degradation and molecular glues.

CiteScore

CiteScore
7.3
SJR
0.883
SNIP
0.816
Subject Rank Percentile
ChemistryOrganic Chemistry
43 / 211 79%

Journal Statistics

Monthly
Issues/Year
Submission to First Editorial Decision (Median Days): 6.2 Submission to First Decision with Peer Review (Median Days): 27.5 Submission to Accept (Median Days): 60.9 Accept to ASAP Publication (Median Days): 5.8
Review Cycle
Article Processing Fee

Submission Information

Submission Website:

https://acs.manuscriptcentral.com/acs

Accepted Types:

Letters
Notes
Technology Notes
Innovations
Viewpoints
Letters to the Editor
Patent Highlights

Related Articles

Front matter

Other

DOI: 10.1039/AN94368FP011

Erratum

Other

DOI: 10.1039/AN938630421B

Food and drugs

Other

DOI: 10.1039/AN942670231B

Legal notes

Other

DOI: 10.1039/AN940650221B

Front cover

Other

DOI: 10.1039/AN94368FX017

Inorganic

Other

DOI: 10.1039/AN942670113B

You might also like

Compound Q&A

What is Ethyl 3-cyclohexylpropanoate (CAS: 10094-36-7)?

Ethyl 3-cyclohexylpropanoate is a clear, colorless to light yellow liquid with a...

10094-36-7Ethyl 3-cyclohexylpr...
Compound Q&A

How should waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)nicotinic acid (CAS: 34783-31-8) be handled?

Waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl...

34783-31-82-(Hydroxymethyl)-5-...
Compound Q&A

How should waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) be handled?

Waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) sho...

858-46-82,4,6-Tris(pentafluo...
Compound Q&A

What precautions should be taken when handling Chloroac-nle-oh (CAS: 56787-36-1)?

When handling Chloroac-nle-oh (CAS: 56787-36-1), it is essential to wear appropr...

56787-36-1Chloroac-nle-oh
Compound Q&A

What industries use Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate (CAS: 752244-05-6)?

Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate is primarily used in the...

752244-05-6Ethyl 6-phenylimidaz...
Compound Q&A

Are there alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis?

Alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis ...

55095-15-3alpha-(2-Bromophenyl...
Compound Q&A

How should waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) be handled?

Waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) should be managed...

139585-48-12-Chloro-5-methoxypy...
Compound Q&A

What industries use 1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9)?

1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9) is used in various ...

5044-27-91-(4-Methoxyphenyl)-...
Compound Q&A

Are there alternatives to 3-Bromo-5-(N-Boc)aminomethylisoxazole (CAS: 903131-45-3) in synthesis?

There are alternative reagents and compounds that can be used in the synthesis o...

903131-45-33-Bromo-5-(N-Boc)ami...
Compound Q&A

What is Tungsten(IV) oxide (CAS: 12036-22-5)?

Tungsten(IV) oxide, also known as tungsten dioxide, is a chemical compound with ...

12036-22-5Tungsten(IV) oxide
Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.